Landscape Capital Management L.L.C. acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 2,242 shares of the biotechnology company's stock, valued at approximately $1,257,000.
Several other hedge funds and other institutional investors have also bought and sold shares of AXON. Brighton Jones LLC purchased a new position in shares of Axon Enterprise in the 4th quarter valued at $480,000. NewEdge Advisors LLC lifted its stake in shares of Axon Enterprise by 41.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,294 shares of the biotechnology company's stock worth $1,207,000 after purchasing an additional 668 shares during the last quarter. Empowered Funds LLC boosted its position in Axon Enterprise by 8.4% during the first quarter. Empowered Funds LLC now owns 2,028 shares of the biotechnology company's stock valued at $1,067,000 after purchasing an additional 157 shares in the last quarter. Woodline Partners LP boosted its position in Axon Enterprise by 40.6% during the first quarter. Woodline Partners LP now owns 6,932 shares of the biotechnology company's stock valued at $3,646,000 after purchasing an additional 2,003 shares in the last quarter. Finally, Sivia Capital Partners LLC purchased a new position in Axon Enterprise in the second quarter valued at about $284,000. Institutional investors own 79.08% of the company's stock.
Insider Buying and Selling at Axon Enterprise
In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 564 shares of Axon Enterprise stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $478.97, for a total transaction of $270,139.08. Following the completion of the sale, the director owned 3,632 shares of the company's stock, valued at approximately $1,739,619.04. The trade was a 13.44% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Patrick W. Smith sold 9,930 shares of the business's stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $548.77, for a total value of $5,449,286.10. Following the sale, the chief executive officer owned 3,031,067 shares in the company, valued at approximately $1,663,358,637.59. The trade was a 0.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 66,989 shares of company stock valued at $35,216,932. Company insiders own 4.20% of the company's stock.
Axon Enterprise Price Performance
Shares of NASDAQ AXON opened at $627.75 on Monday. Axon Enterprise, Inc has a fifty-two week low of $339.01 and a fifty-two week high of $794.29. The company has a market cap of $51.00 billion, a PE ratio of 260.48, a P/E/G ratio of 10.19 and a beta of 1.39. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. The business has a 50-day simple moving average of $543.11 and a two-hundred day simple moving average of $476.99.
Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 EPS for the quarter, topping analysts' consensus estimates of $1.84 by $0.04. The company had revenue of $904.39 million during the quarter, compared to analysts' expectations of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. Axon Enterprise's revenue for the quarter was up 35.3% on a year-over-year basis. During the same period last year, the business earned $2.12 EPS. As a group, equities analysts expect that Axon Enterprise, Inc will post 2.04 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of brokerages have commented on AXON. Royal Bank Of Canada reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, July 21st. The Goldman Sachs Group restated a "buy" rating and issued a $715.00 price target on shares of Axon Enterprise in a report on Thursday, August 6th. Needham & Company LLC reaffirmed a "buy" rating on shares of Axon Enterprise in a research report on Thursday, August 6th. JPMorgan Chase & Co. boosted their price objective on shares of Axon Enterprise from $750.00 to $755.00 and gave the stock an "overweight" rating in a research note on Thursday, May 7th. Finally, Weiss Ratings reissued a "hold (c-)" rating on shares of Axon Enterprise in a research report on Wednesday, August 5th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Axon Enterprise has an average rating of "Moderate Buy" and a consensus price target of $730.92.
View Our Latest Stock Report on Axon Enterprise
Axon Enterprise Profile
(
Free Report)
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Read More
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.